Once daily ciclesonide and twice daily fluticasone propionate are equally effective in the treatment of patients with asthma
R. Buhl, I. Vinkler, P. Magyar, C. Rybacki, M. V. Middle, S. Wolf, R. Engelstätter (Mainz, Konstanz, Germany; Nyíregyháza, Budapest, Hungary; Bydgoszcz, Poland; George East, South Africa)
Source: Annual Congress 2004 - Comparing inhaled corticosteroids
Session: Comparing inhaled corticosteroids
Session type: Thematic Poster Session
Number: 2177
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Buhl, I. Vinkler, P. Magyar, C. Rybacki, M. V. Middle, S. Wolf, R. Engelstätter (Mainz, Konstanz, Germany; Nyíregyháza, Budapest, Hungary; Bydgoszcz, Poland; George East, South Africa). Once daily ciclesonide and twice daily fluticasone propionate are equally effective in the treatment of patients with asthma. Eur Respir J 2004; 24: Suppl. 48, 2177
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Ciclesonide 160 μg once daily compared with fluticasone propionate 250 μg twice daily in maintenance therapy of patients with stable asthma Source: Eur Respir J 2006; 28: Suppl. 50, 205s Year: 2006
Ciclesonide 80 μg or 160 μg once daily is comparable to fluticasone propionate 88 μg twice daily in the treatment of asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 255s Year: 2005
Comparison of ciclesonide (MDI) once daily and fluticasone propionate (Diskus®) twice daily in the treatment of patients with moderate asthma Source: Eur Respir J 2006; 28: Suppl. 50, 666s Year: 2006
Comparable efficacy of ciclesonide 160 μg once daily and budesonide 200 μg twice daily in patients with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005
Effectiveness and safety of fluticasone propionate/salmeterol 250/50mcg administered once daily to patients with persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 309s Year: 2004
Salmeterol/fluticasone propionate combination 50/100 μg bid is more effective than fluticasone propionate 100 μg bid plus montelukast 10 mg once daily in reducing exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 262s Year: 2001
The salmeterol/fluticasone propionate combination 50/100 μg bid is more effective than oral montelukast 10 mg od as a first line therapy in mild and moderate asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 262s Year: 2001
Inhaled budesonide 800 μg once daily versus 400 μg twice daily in patients with mild-to-moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 97s Year: 2001
Once-daily, high-dose inhaled fluticasone propionate and salmeterol in patients having moderate asthma Source: Eur Respir J 2004; 24: Suppl. 48, 125s Year: 2004
Comparison of mometasone furoate dry powder inhaler 400 mcg once daily in the evening with fluticasone propionate metered dose inhaler 250 mcg twice daily in asthma patients previously maintained on fluticasone propionate Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003
Mometasone furoate 400 μg once daily is more efficacious than budesonide 400 μg once daily in improving asthma symptoms in patients with moderate persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 96s Year: 2001
The salmeterol/fluticasone propionate combination 50/100 μg b.i.d is effective as initial maintenance therapy in mild and moderate asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 176s Year: 2001
Efficacy and safety of ciclesonide compared with fluticasone propionate or budesonide in adolescent patients with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 458s Year: 2007
Budesonide/formoterol in a single inhaler once or twice daily provides better asthma control than inhaled fluticasone or budesonide alone in patients with moderate persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 387s Year: 2002
Salmeterol/fluticasone propionate combination (SFC) versus doubling dose of fluticasone propionate (FP) in children with asthma insufficiently controlled on moderate doses of inhaled corticosteroids Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
Once daily ciclesonide (80 µg or 320 µg) is equally effective as budesonide 200 µg given twice daily: a 12-week study in asthma patients Source: Eur Respir J 2003; 22: Suppl. 45, 410s Year: 2003
Efficacy and safety of combined mometasone furoate/formoterol 100/10μg twice daily in subjects with asthma inadequately controlled on low-dose inhaled corticosteroids Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010
Comparison of once-daily ciclesonide 160 μg versus twice-daily fluticasone propionate 88 μg in children with moderate to severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 711s Year: 2006
The effects of fluticasone propionate/salmeterole 50/100 μg bid in children with asthma versus beclometasone propionate 200 μg BD and fluticasone propionate 100 μg bid dry powder inhaletors Source: Eur Respir J 2004; 24: Suppl. 48, 378s Year: 2004
Low-dose single-inhaler budesonide/formoterol administered once daily is effective in mild-persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 158s Year: 2001